Imagine trying to cut a very specific piece of a complex puzzle, but your current tool is bulky and requires a huge power station to run. This project replaces those clunky tools with small, sturdy, and water-soluble 'molecular scissors' that are much easier to mass-produce. By redesigning these scissors, they can perform the same precise chemical cuts as the old tools but much faster and with less waste.
Industrial oxidation of hydrocarbons is currently hindered by the use of Cytochrome P450 enzymes, which are expensive, unstable, and require complex regeneration machinery.
Engineered Lytic Polysaccharide Monooxygenases (LPMOs) immobilized on solid supports to mimic and improve upon Cytochrome P450 catalysis.
If you are a drug manufacturer dealing with the high cost of producing drug metabolites and antibiotics — this project developed engineered LPMO catalysts that provide a more robust and scalable alternative to membrane-bound CYPs. This allows for more efficient production of critical medical compounds.
If you are a biofuel producer dealing with the difficulty of breaking down plant materials — this project developed a way to use LPMOs for the oxidative depolymerization of cellulose. This improves the efficiency of creating second-generation bioethanol.
If you are a chemical plant dealing with the instability and complexity of traditional oxidation catalysts — this project developed hybrid nano-catalysts that are water-soluble and rigid. This simplifies the production of high-value fine compounds.
Based on available project data, it replaces membrane-bound CYPs that require expensive machinery and reducing agents like NADPH with small, robust, and easy-to-produce LPMOs.
The project focuses on LPMOs which are described as easy to produce in large scale and are rigid, water-soluble proteins, making them more suitable for industrial scaling than CYPs.
Based on available project data, there is no specific information regarding patents or licensing agreements provided in the report summary.
The project proposes immobilizing the engineered enzymes on solid supports to create a tailored environment for the chemical reaction.
The project period runs from 2022-06-01 to 2025-05-31, suggesting the research phase concludes in mid-2025.
The consortium is purely academic, consisting of 4 university partners from 3 countries (Norway, Austria, Poland). There is a 0% industry ratio, indicating that the project is currently focused on fundamental scientific breakthroughs rather than immediate commercial productization.
Contact the Norwegian University of Life Sciences (NMBU)
Contact us to find a commercial partner to bridge the gap from lab to factory.
